Fundraising FoxAvotres
Hanover, US · Delaware corporation · 1 known investors
Find your way into Avotres
Sign up to find every way you can get introduced to Avotres
- Your email: who you already know at Avotres, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Avotres team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Avotres is a biopharmaceutical company developing therapeutics targeting autoimmune diseases and cancer. Its work centers on a pipeline of drug candidates addressing immune-related conditions.
Founders & leadership
BC
Bruce CooperNamed on SEC filing
DZ
Dan ZhaoNamed on SEC filing
JC
Jihong ChenNamed on SEC filing
XQ
Xi QinNamed on SEC filing
HJ
Hong JiangNamed on SEC filing
AL
Alex LiNamed on SEC filing
JH
John HoughtonNamed on SEC filing
Board
BH
Investors · 1
Reported raises · per SEC filings
Form D private placements$8M disclosed across 2 rounds · 2020–2023
▶$4MraisedMay 2023 · 3 investors · BiotechnologyRule 506(b)
▶$4MraisedMay 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce CooperDirector
- Dan ZhaoDirector
- Jihong ChenDirector
- Xi QinDirector
- Hong JiangDirector
- Alex LiDirector
- John HoughtonExecutive Officer
- Biao HeDirector
- Offering amount
- $4.5M
- Amount sold
- $4M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedFeb 2021 · 3 investors · BiotechnologyRule 506(b)
▶$4MraisedFeb 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Biao HeDirector
- Zhongping SunDirector
- Yan LeiDirector
- Zihao ZouDirector
- Jihong ChenDirector
- Xi QinExecutive Officer
- Hong JiangExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $4M
- Proceeds to insiders
- $125K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
SharecareSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
VerricaVerrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma. Its products serve dermatology prescribers, payers, and patients, with a lead drug-device combination based on topical cantharidin.
ZocdocZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Mindera HealthMindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology. The company operates in the digital health and diagnostics space.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Companies working in the same space as Avotres.
Frequently asked questions
- What does Avotres do?
- Avotres is a biopharmaceutical company developing therapeutics targeting autoimmune diseases and cancer. Its work centers on a pipeline of drug candidates addressing immune-related conditions.
- Who are Avotres's investors?
- Avotres's investors include Foothill Ventures.
- How much funding has Avotres raised?
- Avotres has disclosed $8M raised across 2 rounds.
- Where is Avotres headquartered?
- Avotres is headquartered in Hanover, US.